| Date Filed | Type | Description |
| 09/12/2018 |
3
| McManigle Mark Drew (Chief Liquidating Officer) has filed a Form 3 on Anthera Pharmaceuticals Inc |
| 01/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2018 |
4
| SHANAHAN WILLIAM R JR (Chief Medical Officer) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 567,876 options to buy
@ $1.65, valued at
$937k
|
|
| 01/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2018 |
4
| TRUEX PAUL F (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 84,705 options to buy
@ $1.65, valued at
$139.8k
|
|
| 01/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2018 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 84,705 options to buy
@ $1.65, valued at
$139.8k
|
|
| 09/20/2017 |
4
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Bought 8,550 shares
@ $1.32, valued at
$11.3k
|
|
| 09/15/2017 |
4
| LIU MAY (Principal Accounting Officer) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Disposed of 365 options to buy
@ $96.64, valued at
$35.3k
Disposed of 9 options to buy
@ $96.64, valued at
$869.8
Disposed of 10,938 options to buy
@ $39.04, valued at
$427k
Disposed of 10,000 options to buy
@ $24.16, valued at
$241.6k
Disposed of 843 options to buy
@ $26.4, valued at
$22.3k
Disposed of 15,000 options to buy
@ $12.88, valued at
$193.2k
Disposed of 5,000 options to buy
@ $75.84, valued at
$379.2k
Disposed of 3,750 options to buy
@ $75.94, valued at
$284.8k
Disposed of 926 options to buy
@ $22.88, valued at
$21.2k
Disposed of 10,000 options to buy
@ $28.16, valued at
$281.6k
|
|
| 09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2017 |
4/A
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Bought 10,400 shares
@ $1.432, valued at
$14.9k
|
|
| 09/07/2017 |
4
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Exercised 10,400 shares
@ $1.432, valued at
$14.9k
|
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/22/2017 |
4
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 81,250 options to buy
@ $1.63, valued at
$132.4k
|
|
| 05/22/2017 |
4
| Olson Charles V (Chief Technology Officer) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 43,750 options to buy
@ $1.63, valued at
$71.3k
|
|
| 05/22/2017 |
4
| Dickinson Klara (Chief Regulatory Officer) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 43,750 options to buy
@ $1.63, valued at
$71.3k
|
|
| 05/22/2017 |
4
| LIU MAY (Principal Accounting Officer) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 53,125 options to buy
@ $1.63, valued at
$86.6k
|
|
| 05/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc |
| 03/03/2017 |
4/A
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc |
| 12/08/2016 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 83,910 options to buy
@ $2, valued at
$167.8k
|
|
| 12/08/2016 |
4
| Thompson David E. (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc |
| 12/06/2016 |
4
| TRUEX PAUL F (Executive Chairman) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Disposed of 170,000 options to buy
@ $9.48, valued at
$1.6M
Disposed of 180,000 options to buy
@ $9.48, valued at
$1.7M
|
|
| 12/06/2016 |
4
| THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc |
| 09/22/2016 |
4
| TRUEX PAUL F (CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Exercised 5,008 shares
@ $2.08, valued at
$10.4k
Gifted 5,008 shares
@ $0
Gifted 5,008 shares
@ $0
Exercised 5,008 options to buy
@ $2.08, valued at
$10.4k
|
|
| 08/16/2016 |
3
| SHANAHAN WILLIAM R JR (Chief Medical Officer) has filed a Form 3 on Anthera Pharmaceuticals Inc |
| 06/13/2016 |
4
| Dickinson Klara (Chief Regulatory Officer) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 105,000 options to buy
@ $3.52, valued at
$369.6k
|
|
| 06/13/2016 |
4
| THOMPSON JOHN CRAIG (President & COO) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 170,000 options to buy
@ $3.52, valued at
$598.4k
|
|
| 06/13/2016 |
4
| LIU MAY (Principal Accounting Officer) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 80,000 options to buy
@ $3.52, valued at
$281.6k
|
|
| 06/13/2016 |
4
| Olson Charles V (CHIEF TECHNOLOGY OFFICER) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 100,000 options to buy
@ $3.52, valued at
$352k
|
|
| 06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|